Abstract

The Therapeutic Products Directorate Canada has issued a Notice of Compliance approving extended-release (ER) bupropion

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Past and present of antiobesity agents: focus on monoamine modulators.
Farah E Khorassani ... Shauna Garris
American Journal of Health-System Pharmacy | VOL. 72
Farah E Khorassani, et. al.Farah E Khorassani ... Shauna Garris
01 May 2015
Bupropion HCI Yavaş Salınımlı Formuna Bağlı Jeneralize Tonik Klonik Nöbet
Erhan Dedeoğlu ... Berrin Dedeoğlu
Klinik psikofarmakoloji bulteni = Bulletin of clinical psychopharmacology | VOL. 21
Erhan Dedeoğlu, et. al.Erhan Dedeoğlu ... Berrin Dedeoğlu
01 Dec 2011
Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study.
Anna I Guerdjikova ... Brandon Walsh
Advances in therapy | VOL. 34
Anna I Guerdjikova, et. al.Anna I Guerdjikova ... Brandon Walsh
16 Sep 2017
Persistent Auditory Hallucinations That Are Unresponsive to Antipsychotic Drugs
Stephen E Nicolson ... Helen S Mayberg
American Journal of Psychiatry | VOL. 163
Stephen E Nicolson, et. al.Stephen E Nicolson ... Helen S Mayberg
01 Jul 2006
View more papers

More From: Inpharma Weekly

Paper Title
Journal
Date
Author
The Simpsons could describe the future of medical publishing
Inpharma Weekly | VOL. -
01 Dec 2008
I scream, you scream, we all scream for ice cream
&Na;
Inpharma Weekly | VOL. -
&Na; &Na;
01 Dec 2008
Universal HIV testing and immediate ART of benefit
Inpharma Weekly | VOL. -
01 Dec 2008
CERE 120 has failed to demonstrate any distinct benefit for patients with Parkinson's disease
&Na;
Inpharma Weekly | VOL. -
&Na; &Na;
01 Dec 2008
View more papers